消化系癌的进展形式中,肝脏转移及腹膜播散成为根治手术的重大障碍,因此,必需对原发灶积极摘除的同时,对残存的转移灶进行有效的化疗。作者报告17例消化系癌患者,以不同的投药途径使用顺铂,就其抗癌效果及副作用进行探讨。17例患者为1982年6～12月应用顺铂治疗者,有肺、胃、直肠、肝、子宫等原发癌的第Ⅳ期病例或再发病例,对其中12例采用动脉内注药或腹腔内投药者,进行抗癌效果的评价,包括不能手术的肝癌1 In the progressive form of digestive cancer, liver metastasis and peritoneal dissemination are major obstacles to radical surgery. Therefore, it is necessary to perform active chemotherapy for residual metastases while actively removing the primary tumor. The authors reported 17 cases of patients with digestive system cancer, using different routes of administration of cisplatin, to discuss its anti-cancer effect and side effects. Seventeen patients were treated with cisplatin from June to December 1982. They had stage IV or recurrent cases of primary cancers such as lung, stomach, rectum, liver, and uterus. Among them, 12 cases received intraarterial injections or Intra-abdominal administration of anti-cancer effects, including inoperable liver cancer1